VKVolodymyr Mykhailovych Kopchak

Volodymyr Mykhailovych Kopchak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Volodymyr Mykhailovych Kopchak has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience in the Treatment of Pancreatic Hemorrhage as a Complication of Chronic Pancreatitis

    by I. V. Khomiak, V. M. Kopchak, V. P. Shkarban, V. A. Kondratiuk, I. A. Mazanovych, V. O. Shatalo

    Objective. To systematize the results of various treatment methods for patients with pancreatic hemorrhage as a complication of chronic pancreatitis. Materials and Methods. A retrospective analysis was conducted of the treatment outcomes of 47 patients with pancreatic hemorrhage against a background of chronic pancreatitis during the period from 2015 to 2025. There were 36 men and 11 women aged 25 to 71 years. The mean age of the patients was (47 ± 11) years. The diagnosis was verified based on the clinical triad (pain, bleeding, hyperamylasemia) and data from multislice computed tomography of the abdominal organs and digital subtraction angiography, which confirmed the presence of pseudocysts or pseudoaneurysms. The treatment strategy consisted of performing endovascular interventions (in 33 patients), open surgeries (in 9 patients), and conservative therapy (in 5 patients). Treatment efficacy was assessed based on the frequency of hemostasis achievement, recurrence, and mortality rates. Results. Clinically, pain was the predominant symptom in all patients (100%), while overt signs of gastrointestinal bleeding varied (melena–12.8%, hematemesis–4.3%, and a combination of symptoms–4.2%). Anemia was detected in 34.0% of patients, and hyperamylasemia in 23.4%. According to imaging data, the main sources of bleeding were the gastric and duodenal (42.9%) and splenic (30.0%) arteries; calcifications were detected in the immediate vicinity of the affected vessel in 42.6% of patients. Endovascular hemostasis, performed in 33 (70.2%) patients, had a technical success rate of 100%. The primary clinical efficacy of the method was 61.7%, and the overall efficacy after repeat angiographic interventions was 70.2%. Surgical treatment, performed in 9 (19.2%) patients with recurrences or hemodynamic instability, had a 100% success rate. The overall efficacy of the multimodal approach was 97.9%, mortality was 2.1%, and the recurrence rate was 19.2%. Predictors of an unfavorable course were identified as massive blood loss, infection of a pseudocyst, localization in the gastro-duodenal artery basin, and the presence of pararterial calcifications. Conclusions. The implementation of a multimodal approach with the priority use of endovascular hemostasis as a first-line method is a highly effective and safe strategy for treating pancreatic hemorrhage, allowing for successful clinical outcomes with a minimal mortality rate.

  • Open Access

    Treatment tactics for patients with borderline resectable and locally advanced pancreatic cancer

    by V. M. Kopchak, L. O. Pererva, O. V. Duvalko, V. V. Khanenko, V. I. Trachuk, V. Y. Bondar, Z. Y. Holobor

    Objective – to evaluate the outcomes of extended pancreatic resections in the treatment of patients with borderline resectable and locally advanced pancreatic cancer and to identify strategies for improving the effectiveness of these procedures. Materials and methods. Between 2010 and 2023, a total of 874 pancreatic resections were performed for patients with pancreatic adenocarcinoma: 142 distal pancreatosplenectomies (16.2%), 706 pancreaticoduodenectomies (80.8%), and 26 total pancreatectomies (3.0%). The cohort included 388 females (44.4%) and 486 males (55.6%), with a mean age of 57.7±10.5 years (range: 22 – 81). Extended pancreatic resections were conducted in 202 (23.1%) patients, comprising 130 extended pancreaticoduodenectomies (64.4%), 58 extended distal pancreatosplenectomies (28.7%), and 14 extended total pancreatectomies (6.9%). A total of 144 (71.3%) patients underwent pancreatic resections with venous resections, 13 (6.4%) with arterial resections, 3 (1.5%) with combined vascular resections, and 42 (20.8%) with resections of adjacent organs. Results. Postoperative complications were observed in 248 patients (36.9%) in the standard resection group and in 84 patients (41.6%) in the extended resection group (χ2=1.4; p=0.22), with no statistically significant difference. The mortality rate was 2.6%, with 23 deaths: 16 (2.4%) after standard pancreatic resections and 7 (3.5%) after extended pancreatic resections, indicating no statistically significant difference (χ2=0.71; p=0.39). Implementation of a personalized treatment algorithm increased the median survival of patients with borderline resectable and locally advanced pancreatic head cancer from 19 to 28 months (χ2=1.7; p=0.18) and the five‑year survival from 22% to 28.5%. For patients with pancreatic cancer of the body and tail, median survival increased from 22 to 36 months (χ2=1.78; p=0.18) and five‑year survival from 24% to 34% (χ2=1.78; p=0.18). Conclusions. The results suggest that morbidity and mortality after extended pancreatic resections are comparable to those observed after standard pancreatic resections. Extended resections are feasible and can increase the number of patients eligible for radical surgery. Implementation of the developed treatment algorithm was associated with improved median survival in patients with borderline resectable and locally advanced pancreatic cancer.

  • Open Access

    The first in Ukraine "Triangle" operation (pancreaticoduodenectomy) for malignant tumor of the pancreatic head

    by V. M. Kopchak, L. O. Pererva, P. A. Azadov

    The first in Ukraine "Triangle" operation (pancreaticoduodenectomy) for malignant tumor of the pancreatic head

  • Treatment of patients with pancreatic injuries during the war after Russian invasion of Ukraine

    by Oleksandr Usenko, Volodymyr Kopchak, Liudmyla Pererva, Ihor Khomiak, Viktor Shkarban, Ivan Tereshkevych, Volodymyr Trachuk, Vitalii Kondratiuk

  • Pancreatic Battlefield Injuries During Ukraine War

    by Volodymyr M Kopchak, Yuriy O Khilko, Liudmyla O Pererva, Artem O Danyliuk, Iurii Snopok

    Introduction: Battlefield pancreatic injury (BPI) is rare and difficult to diagnose and treat. Publications on this topic are limited. The aim of this study was to analyze our initial experience in treating BPI since the beginning of the full-scale Russian invasion of Ukraine. Materials and Methods: We retrospectively analyzed the medical records of military personnel treated between February and December 2022. XLSTAT’s variable characterization tool, using an indicator called test value (TV), was used to assess possible associations between variables. Results: BPIs were found in 11 of 252 (4.4%) patients with an average age of 36.6 ± 10.1 years. The main cause of injury was explosion (6/11, 54.6%) and gunshot (2/11, 18.2%). Head of pancreas injuries were the most common (5/11, 45.5%), followed by distal pancreas injuries (4/11, 36.4%). Our treatment was predominantly interventional (5/11, 45.5%) and/or surgical drainage (4/11, 36.4%). Two patients (18.2%) were treated conservatively. One patient (9.1%) underwent cystojejunostomy for pseudocyst and another (9.1%) distal pancreatectomy. There was a positive association between the number of frontline operations and concomitant jejunal (TV 2.289; P = .022) and ileal (TV 2.211; P = .027) injuries. There was also a positive association between stoma formation at primary surgery and ileal injury (TV 2.000; P = .045) and pancreatic fistula and concomitant rib fractures (TV 2.484; P = .013). Conclusions: BPIs would be expected in victims with explosive damage to the upper body, often located in the head of the pancreas. Concomitant small bowel injury and rib fractures are associated with increased frequency of stoma formation, number of primary surgeries, and pancreatic fistula. Most patients can be successfully managed with interventional or surgical drainage without resection.


  • Open Access

    Early biliary complications after pancreaticoduodenectomy

    by O. Usenko, V. Kopchak, P. Ogorodnyk, I. Khomyak, O. Lytvyn, A. Deinichenko, S. Motelchuk

    Objective. To evaluate the frequency, risk factors and methods of treatment of early biliary complications after pancreaticoduodenectomy. Materials and Methods. A retrospective and prospective study was conducted, which included 451 patients who were treated at the National Research Center of Surgery and Transplantation named after A.A. Shalimov of the National Academy of Medical Sciences of Ukraine from January 2015 to December 2022. There were 235 men (52.1%) and 216 women (47.9%). The age of patients ranged from 35 to 80 years, with a mean age of (61± 9.3) years. Pancreaticoduodenectomy with preservation of the Traverso pancreas was performed in 135 patients, and with removal of the Whipple pancreas in 316 patients. The study patients underwent clinical, laboratory, bacteriological and instrumental examinations. Results. In 55 (12.2%) patients, early biliary complications occurred: in 6 (1.3%) - hepaticojejunoanastomosis stenosis, in 13 (2.9%) - temporary jaundice, in 10 (2.2%) - biliary hemorrhage and in 26 (5.8%) - cholangitis. In 6 patients with hepaticojejunoanastomosis stenosis, the diameter of the common bile duct was less than 5 mm, which statistically significantly (p < 0.001) influenced the development of early biliary complications, and 3 of these patients underwent repeated surgery. Temporary jaundice resolved spontaneously in all 13 patients. The jaundice stopped spontaneously in 5 patients, and the other 5 patients required minimally invasive treatment (4) or relaparotomy (1). Recurrent episodes of cholangitis were observed in 26 patients after discontinuation of antibiotic therapy. No patient died. The reoperation rate was 7%. Minimally invasive methods were successful in 11% of patients. Conclusions. The risk factors for the occurrence of biliary fistula after pancreaticoduodenectomy, the frequency of which was 2%, include male gender, obesity, low serum albumin levels, endobiliary stenting in the preoperative period, common bile duct diameter less than 5 mm, segmental bile duct anastomoses, and the fact that biliary leakage from hepaticojejunoanastomosis is associated with biliary wall weakness. The use of minimally invasive technologies is effective in the treatment of early biliary complications after pancreaticoduodenectomy. Prevention of early biliary complications after pancreaticoduodenectomy includes precision surgical technique, selection of adequate suture material and assessment of all risk factors for their occurrence.


  • Open Access

    Effectiveness of duodenal and gastrojejunostomy using suturing devices in pancreaticoduodenectomy

    by О. Ю. Усенко, В. М. Копчак, П. В. Огородник, І. В. Хомяк, О. І. Литвин, А. Г. Дейниченко, С. О. Мотельчук

    Objective. To study the effect of the formed hardware duodeno– and gastrojejunoanastomoses on the development of gastric emptying retardation. Materials and methods. A study was conducted involving 136 patients from January 2019 to June 2024 who underwent pancreaticoduodenectomy with preservation of the Traverso and removal of the Whipple. Patients were divided into two groups: control group – 102 patients (retrospective part of the study) and main group – 34 patients (prospective part of the study). In turn, patients in the control group were divided into two subgroups: K1 – 26 (25.5%) patients with gastric emptying slowdown and K2 – 76 (74.5%) patients without signs of gastric motor function disorders. The main group was also divided into two subgroups: O1 – 5 (14.7%) patients who developed slowed gastric emptying, and O2 – 29 (85.3%) patients without symptoms of slowed gastric evacuation function. The standard surgical technique was used in the treatment of patients in the control group, and the proposed tactics of forming duodenojejuno– and gastrojejunoanastomoses using suturing devices and measures to prevent the occurrence of gastric emptying retardation in the pre–, intra– and postoperative periods were used in the treatment of patients in the main group. Results. In the case of duodenojejuno– or gastrojejunoanastomosis formation using stapling staplers, the frequency of postoperative delayed gastric emptying decreased from 25.5 to 14.7% (p<0.05), the duration of surgery – from 403 to 362 minutes (p=0.027). The duration of the operation in subgroup K1 was 393 min, K2 – 406 min, in subgroup O1 – 390 min, O2 – 363 min and was not statistically significantly associated with the occurrence of gastrostasis (p = 0.5). The duration of the nasogastric tube stay was shorter in the intervention group than in the control group – 2 and 7 days, respectively (p < 0.0001). The number of days before the start of liquid food intake was also shorter in the intervention group than in the control group – 3 and 7 days, respectively (p < 0.0001). Conclusions. The formation of a stapler anastomosis reduces the risk of delayed gastric emptying after pancreaticoduodenectomy, regardless of whether the gatekeeper was resected, from 25.5 to 14.7% (p<0.05) and accelerates the postoperative recovery of patients with gastrostasis, while not increasing the risk of clinically significant postoperative external pancreatic fistula: 14.7% in the control group and 8.8% in the main group (p=0.001).

  • Open Access

    Modern endovascular treatment strategies in the management of postpancreatectomy haemorrhage in patients with pancreatic cancer

    by V. M. Kopchak, L. O. Pererva, V. A. Kondratiuk, I. V. Khomiak, O. V. Duvalko, I. A. Mazanovych, V. V. Khanenko, V. I. Trachuk, P. A. Azadov

    Objective — to determine the occurrence and management of postpancreatectomy haemorrhage in pancreatic cancer patients, as well as to identify effective treatment strategies to improve patient outcomes. Materials and methods. From January 2010 to December 2022, 878 patients who underwent radical pancreatic resections for malignant tumours were retrospectively analysed. Patients were divided into two groups. The main group consisted of 500 patients who were treated in the clinic from 2016 to 2022. In the main group, postpancreatectomy haemorrhage occurred in 31 (6.2%) patients. These patients were treated according to our diagnostic and treatment algorithm, using endovascular techniques as the first step of treatment. The comparison group consisted of 378 patients who were treated in our department from 2010 to 2015. In the comparison group, postpancreatectomy haemorrhage occurred in 20 (5.3%) patients. These patients were treated according to standard approaches. The definition of postpancreatectomy haemorrhage proposed by the International Study Group of Pancreatic Surgery was used in our research. Results. Out of 31 patients in the main group, 16 (51.6%) had endovascular embolisation. A total of 10 patients underwent endovascular occlusion, whereas 5 patients experienced cessation of bleeding with the use of a stent graft. Angiography did not detect the cause of bleeding in 3 (9.7%) individuals in the main group. They underwent laparotomy with subsequent haemostasis. 11 (35.5%) patients underwent open surgical interventions. In the main group, one (3.2%) patient died due to the emergence of infectious complications after laparotomy and subsequent haemostasis. 2 (10%) patients underwent endovascular haemostasis, while 15 (75%) patients underwent relaparotomy with haemostasis. In the comparison group, 6 (30%) patients died after open relaparotomies. Conclusions. The initial course of action for managing postpancreatectomy haemorrhage involves the implementation of endovascular techniques, wherein stent grafts are used to address bleeding originating from the main blood vessel. The application of advanced treatment strategies that optimised the use of minimally invasive endovascular techniques resulted in a notable decrease in the mortality rate associated with postpancreatectomy bleeding from 30% to 3.2% (χ2=7.3, p=0.006). Ensuring 24/7 access to endovascular treatment, which can be provided exclusively in high‑volume centres, is imperative for improving the treatment outcomes of patients with pancreatic and periampullary cancer.


  • Open Access

    Modern principles of diagnosis and treatment of post–pancreatic resection bleeding

    by V. M. Kopchak, L. O. Pererva, V. A. Kondratiuk, I. A. Mazanovych, P. A. Azadov, V. V. Khanenko, V. I. Trachuk

    Objective. To improve the results of treatment of patients with post–pancreatic resection bleeding. Materials and methods. The results of treatment of 827 patients who underwent radical resection of the pancreas for malignant tumours in the period from 2010 to 2021 were analysed. The patients were divided into two groups: the main group – 449 patients who were treated at the clinic from 2016 to 2021, and the control group – 378 patients who were treated in the clinic from 2010 to 2015. Postpancreatectomy bleeding occurred in 27 (6.0%) patients in the main group who were treated according to the developed diagnostic and therapeutic algorithm with the maximum use of endovascular techniques, and in 20 (5.3%) patients in the control group who received standard treatment. Results. X–ray endovascular bleeding control was performed in 14 (51.9%) of 27 patients in the main group: X–ray endovascular occlusion – in 9, by means of stent graft placement – in 5. In 3 (11.1%) patients of the main group, the source of bleeding was not detected during angiography, and they underwent laparotomy with subsequent bleeding control. Complications after X–ray endovascular occlusion occurred in 1 (11.1%) patient, and there were no complications after stent graft placement. Open surgical interventions were performed in 13 (48.1%) patients. One (3.7%) patient died after laparotomy with bleeding control due to the development of further purulent–septic complications. In the control group, X–ray endovascular bleeding control was performed in 3 (15%) patients, and relaparotomy with bleeding control in 17 (85%) patients. 6 (30%) patients died after open reoperative interventions. Conclusions. Endovascular techniques for stopping post–pancreatic transplantation bleeding are highly effective and safe with favourable technical and clinical results. They are advisable as the first step in the treatment of postpancreatic surgery bleeding with stent grafts in case of bleeding from the great vessels.

  • Open Access

    Prevention strategies for reducing the incidence of postoperative pancreatic fistulas in patients following pancreatoduodenectomy

    by V. M. Kopchak, L. O. Pererva, V. O. Kropelnytskyi, V. V. Khanenko, P. A. Azadov, Z. Y. Holobor

    Objective — to design and implement a preventive approach aimed at reducing the incidence of postoperative pancreatic fistulas and other complications following pancreatoduodenectomy in patients diagnosed with cancer of the pancreatic head and periampullary region. Materials and methods. The present study involved the analysis of treatment outcomes for a cohort of 370 patients diagnosed with cancer of the pancreatic head and periampullary region who underwent pancreatoduodenectomy during the years 2015—2021. Between November 2018 and December 2021, a total of 141 patients were operated on using our modified pancreatic fistula risk score, an evaluation of preoperative sarcopenia status, and our risk mitigation strategies aimed at minimising postoperative complications. These patients made up the main group. The comparison group included a total of 229 patients. The surgical procedures were conducted between January 2015 and October 2018, employing generally accepted methods. However, the risk evaluation of potential pancreatic fistulas, the presence of sarcopenia, and the implementation of suggested prevention strategies were not taken into account. Results. The incidence of postoperative complications was significantly higher in the comparison group, with complications occurring in 94 (41.0%) patients, while in the main group, complications occurred in 43 (30.5%) patients (χ2=4.1; p=0.04). In the main group, a total of 16 (11.3%) patients experienced a clinically relevant grade B postoperative pancreatic fistula, which was significantly lower than in the comparison group, where the grade B or grade C fistula occurred in 64 (27.9%) patients (χ2=14.2; p=0.0002). In the main group, 2 patients died; the mortality rate was 1.4%. In the comparison group, 5 patients died, and the mortality rate was 2.2%. This rate was shown to be higher (χ2=0.27; p=0.6) when compared to the main group. Conclusions. The implemented approach demonstrated a substantial reduction in the incidence of postoperative pancreatic fistulas from 27.9% to 11.3%, the number of postoperative complications from 41.0% to 30.5%, and mortality from 2.2% to 1.4%.